Five new papers today — here are the top four. Paper one — prehospital TXA looks like it helps trauma patients in fibrinolytic shutdown. Paper two — opioid-associated cardiac arrests fare about the same as other arrests. Paper three — bloods in the first six hours after ROSC sort patients into three phenotypes with very different outcomes. Paper four — no prehospital variable reliably picks which pelvic fractures a binder will help.

Paper one — The Journal of Trauma and Acute Care Surgery. A pooled analysis of two prospective prehospital TXA trials, twelve hundred and forty-nine trauma patients. Researchers stratified patients by fibrinolytic phenotype using thromboelastography. Thirty-day mortality was fourteen point five per cent in the fibrinolytic shutdown group, against six point five per cent with physiological fibrinolysis. The number that jumps out at me — shutdown patients randomised to TXA had roughly a third the risk of death. So the drug may help exactly the patients who look hardest to save. TXA is standard kit in nearly every Australian ambulance service — the ACT is the notable exception. The big caveat: the fibrinolysis phenotyping came from bloods on hospital arrival, not roadside, and this is a subgroup analysis of pooled trials — hypothesis-generating rather than practice-changing.

Paper two — Resuscitation. A retrospective registry cohort from British Columbia, ten thousand seven hundred and eighty-six EMS-treated out-of-hospital cardiac arrests, thirteen per cent of them opioid-associated. Overall, opioid-associated arrests had essentially the same odds of survival with a favourable neurological outcome as undifferentiated arrests. But the usual predictors behaved differently — sex, initial rhythm and witnessed status all interacted with opioid status, so standard prognostic models can be skewed when opioid cases are mixed in. The catch: opioid classification relied on post-mortem toxicology and death certificates, so misclassification is likely. Context more than action, but it matters for how arrest data reads.

Paper three — also Resuscitation. A ten-year national cohort from Singapore, fifteen hundred or so resuscitated adults with presumed cardiac arrest. Laboratory values drawn within six hours of ROSC sorted patients into three phenotypes — homeostatic, immune-dysregulated, and multi-organ dysfunction. The multi-organ dysfunction group had roughly double the odds of poor neurological recovery compared with the others, and the mortality gap was still there at three years. This is in-hospital data, so it shapes handover and post-arrest care conversations more than anything roadside. And it's exploratory — a derivation study from a single country's database, waiting on external validation.

Paper four — The American Surgeon. A retrospective imaging review at a tertiary trauma centre, two hundred and ninety-eight adults with CT-confirmed pelvic ring injuries. Four orthopaedic surgeons classified whether a binder would actually be mechanically favourable. Favourable in just seventeen per cent, neutral in twenty-eight, and potentially unfavourable in fifty-six per cent. And no prehospital variable — hypotension, tachycardia, shock index, mechanism of injury — discriminated well. The best performer, Injury Severity Score, managed only zero point six five. Binders are on nearly every Australian truck, so crews will keep applying them empirically — the point is that physiology alone won't tell you which fracture pattern you're dealing with. Caveats: it's a single-centre imaging review classified by surgeons, and binder position on CT may not reflect how it sat in the field.

Quick recap. One — TXA was linked to lower death rates in trauma patients with fibrinolytic shutdown. Two — opioid-associated cardiac arrests fare about the same as other arrests. Three — early post-ROSC bloods split patients into three phenotypes with very different outcomes. Four — prehospital variables can't pick which pelvic fractures benefit from a binder.

That's the roundup for Sunday the eleventh of October. Also on the dashboard today — Italian HEMS trauma mortality predictors. Back tomorrow.